Testing & Tracking NACs effect is often inferred through glutathione levels, which are measurable but may not fully reflect availability in all tissues
Researchers are investigating genetic variants in GLP-1 receptor pathways, gut microbiome profiles, and baseline hormone levels to determine who will respond best to GLP-1 therapy, who might benefit from dual agonists, and who is more prone to side effects
Ongoing management
Conclusions For patients who have had insufficient weight loss or weight recurrence following sleeve gastrectomy, conversion to RYGB offers greater, long-term weight loss compared to GLP1-RAs
obniajc CK), zmniejsza ble miniowe (DOMS) i skraca czas potrzebny na regeneracj po intensywnym wysiku
Schmidt PT, Ljung T, Hartmann B, Hare KJ, Holst JJ, Hellstrm PM (2005) Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY